Literature DB >> 9261449

A conditional self-inactivating retrovirus vector that uses a tetracycline-responsive expression system.

J J Hwang1, L Li, W F Anderson.   

Abstract

We developed a novel conditional self-inactivating (C-SIN) vector, TL-SN, by replacement of the enhancer-promoter of the 3' long terminal repeat of Moloney murine leukemia virus with a synthetic tetracycline operator-cytomegalovirus promoter (tetP) from the tetracycline-responsive expression system (TRES). The other component of the TRES, a chimeric transactivator (tTA), was stably incorporated into PA317 amphotropic packaging cells, thus generating the packaging cell line PA317-tTA. C-SIN amphotropic G418-resistant virus particles were generated with a titer of 2 x 10(5) CFU/ml within 2 days of transinfection of PA317-tTA cells with TL-SN ecotropic virus particles. This titer was approximately 2 log units higher than that obtained by transinfection of parental PA317 cells and was due to the high level of viral transcripts originating from the tetP promoter at the 5' end of the transduced vector in the presence of tTA. Our C-SIN vector has the potential for use in human gene therapy since it incorporates the advantages of previous SIN vectors in having weak tetP promoter activity (in the absence of tTA in target cells) while at the same time achieving high viral titers with PA317-tTA packaging cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9261449      PMCID: PMC192013     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  A promoterless retroviral vector indicates that there are sequences in U3 required for 3' RNA processing.

Authors:  J P Dougherty; H M Temin
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

2.  Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production.

Authors:  A D Miller; C Buttimore
Journal:  Mol Cell Biol       Date:  1986-08       Impact factor: 4.272

3.  Genes with promoters in retrovirus vectors can be independently suppressed by an epigenetic mechanism.

Authors:  M Emerman; H M Temin
Journal:  Cell       Date:  1984-12       Impact factor: 41.582

4.  Multiple arrangements of viral DNA and an activated host oncogene in bursal lymphomas.

Authors:  G S Payne; J M Bishop; H E Varmus
Journal:  Nature       Date:  1982-01-21       Impact factor: 49.962

5.  Handicapped retroviral vectors efficiently transduce foreign genes into hematopoietic stem cells.

Authors:  R G Hawley; L Covarrubias; T Hawley; B Mintz
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

6.  Comparison of promoter suppression in avian and murine retrovirus vectors.

Authors:  M Emerman; H M Temin
Journal:  Nucleic Acids Res       Date:  1986-12-09       Impact factor: 16.971

Review 7.  Human gene therapy comes of age.

Authors:  A D Miller
Journal:  Nature       Date:  1992-06-11       Impact factor: 49.962

8.  Proviral deletions and oncogene base-substitutions in insertionally mutagenized c-myc alleles may contribute to the progression of avian bursal tumors.

Authors:  D Westaway; G Payne; H E Varmus
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

9.  Transcription of three c-myc exons is enhanced in chicken bursal lymphoma cell lines.

Authors:  M Linial; M Groudine
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

10.  Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells.

Authors:  S F Yu; T von Rüden; P W Kantoff; C Garber; M Seiberg; U Rüther; W F Anderson; E F Wagner; E Gilboa
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

View more
  3 in total

1.  Retroviral vectors containing Tet-controlled bidirectional transcription units for simultaneous regulation of two gene activities.

Authors:  Rainer Loew; Elisa Vigna; Dirk Lindemann; Luigi Naldini; Herman Bujard
Journal:  J Mol Genet Med       Date:  2006-07-17

2.  Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery.

Authors:  R Zufferey; T Dull; R J Mandel; A Bukovsky; D Quiroz; L Naldini; D Trono
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

3.  Inhibition of histone deacetylation in 293GPG packaging cell line improves the production of self-inactivating MLV-derived retroviral vectors.

Authors:  Diana E Jaalouk; Milena Crosato; Pnina Brodt; Jacques Galipeau
Journal:  Virol J       Date:  2006-04-07       Impact factor: 4.099

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.